Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Reactogenicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05297994
What this trial is testing

Trial of the Reactogenicity, Safety and Immunogenicity of the Flu-M Vaccine Manufactured by FSUE SPbSRIVS FMBA

Who this might be right for
Influenza
St. Petersburg Research Institute of Vaccines and Sera 400
Testing effectiveness (Phase 2)Study completedNCT01061541
What this trial is testing

Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™

Who this might be right for
Haemophilus Influenzae Type b
GlaxoSmithKline 192
Testing effectiveness (Phase 2)Active Not RecruitingNCT06984094
What this trial is testing

Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults

Who this might be right for
RSV InfectionHuman Metapneumovirus InfectionParainfluenza Infection
Clover Biopharmaceuticals AUS Pty 612
Early research (Phase 1)Study completedNCT00666380
What this trial is testing

Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in Kenya

Who this might be right for
Malaria
U.S. Army Medical Research and Development Command 26
Testing effectiveness (Phase 2)Study completedNCT00538473
What this trial is testing

Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

Who this might be right for
Influenza
GlaxoSmithKline 68
Large-scale testing (Phase 3)Study completedNCT00920374
What this trial is testing

Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults

Who this might be right for
Influenza
GlaxoSmithKline 118
Large-scale testing (Phase 3)Ended earlyNCT04980391
What this trial is testing

A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 384
Very early researchNot Yet RecruitingNCT07394426
What this trial is testing

A Phase I Study of PepGNP-ChikV in Healthy Volunteers

Who this might be right for
ChikungunyaChikungunya FeverChikungunya Virus Infection+2 more
Gylden Pharma Ltd 40
Testing effectiveness (Phase 2)Study completedNCT05375838
What this trial is testing

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old

Who this might be right for
SARS-CoV-2Influenza
ModernaTX, Inc. 550
Post-approval studies (Phase 4)Study completedNCT05406908
What this trial is testing

Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseases

Who this might be right for
Bullous DermatosesPsoriasisCOVID-19 Vaccines
Mahidol University 109
Early research (Phase 1)Study completedNCT01657526
What this trial is testing

Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) Vaccine

Who this might be right for
Respiratory Disorders
GlaxoSmithKline 48
Large-scale testing (Phase 3)Study completedNCT05827978
What this trial is testing

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

Who this might be right for
Seasonal Influenza
ModernaTX, Inc. 8,411
Early research (Phase 1)Study completedNCT01905215
What this trial is testing

Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines

Who this might be right for
Infections, Respiratory Syncytial Virus
GlaxoSmithKline 128
Large-scale testing (Phase 3)UnknownNCT01763268
What this trial is testing

Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants

Who this might be right for
ImmunogenicityReactogenicity
Queen Sirikit National Institute of Child Health 200
Testing effectiveness (Phase 2)Study completedNCT07155499
What this trial is testing

A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V 1] and an Apple Allergen [MAL D 1]) in Patients With Birch Pollen Allergic Rhinitis.

Who this might be right for
Rhinitis, Allergic, Seasonal
AO GENERIUM 150
Testing effectiveness (Phase 2)Study completedNCT03443427
What this trial is testing

Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the Vaccine

Who this might be right for
Respiratory Disorders
GlaxoSmithKline 200
Large-scale testing (Phase 3)Study completedNCT00346723
What this trial is testing

Annual Study to Investigate Inactivated Subunit Influenza Vaccine for the 2006/2007 Influenza Season in Europe.

Who this might be right for
Healthy Volunteers
Solvay Pharmaceuticals 120
Early research (Phase 1)Study completedNCT05525546
What this trial is testing

Salmonella Conjugates CVD 2000: Study of Responses to Vaccination With Trivalent Salmonella Conjugate Vaccine to Prevent Invasive Salmonella Disease

Who this might be right for
Risk Reduction
University of Maryland, Baltimore 82
Testing effectiveness (Phase 2)Study completedNCT00196950
What this trial is testing

Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 Years

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 50
Early research (Phase 1)Study completedNCT04953078
What this trial is testing

Evaluate Safety, Tolerability, and Reactogenicity of an RBD-Fc-based Vaccine to Prevent COVID-19

Who this might be right for
Coronavirus
Baiya Phytopharm Co., Ltd. 48
Next Page